Marcus Autism Center and Emory University School of Medicine have been awarded up to $17.25 million to join an international clinical trials network focused on children with profound autism and related neurodevelopmental conditions.
Announced Sept. 8, the award comes from Aligning Research to Impact Autism, or ARIA. It will support research into precision medicine and new treatments through the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network. Marcus Autism Center is a subsidiary of Children’s Healthcare of Atlanta.
The award brings the center’s research funding this year to nearly $40 million. Earlier in 2026, it received $21.9 million from The Marcus Foundation for a study of behavioral, brain and genomic biomarkers in children across the autism spectrum and with related genetic conditions.
Center director and principal investigator Dr. Ami Klin said children with profound autism have historically been difficult to study and treat. The center specializes in care for children who may have significant intellectual disabilities, communication challenges and severe behavioral needs.
Please note! Comments are published by readers. The opinions expressed may not reflect the position of the editorial team. USCT is not responsible for the content of readers' opinions and asks authors to observe moral standards, not to incite national or racial hatred, and to avoid rudeness. Think before you speak. You are responsible for your words! By publishing an opinion, you agree to the rules! If this request is ignored, USCT reserves the right to deprive the user of the ability to leave comments.